Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in early rheumatoid arthritis (CAR-ERA)
NCT02150473Phase 3Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Oct 2014
- Primary completion
- Sep 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Heinrich Heine University Düsseldorf. Started Oct 2014; status: terminated.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02150473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150473.